Subgroup | No. of subjects | miR16 levelsa | |||||
---|---|---|---|---|---|---|---|
All | p value | CAF | p value | NF | p value | ||
Sex | |||||||
 Male | 19 | 925 [441–2120] | 0.746 | 925 [487–1961] | 0.570 | 1180 [312–2109] | 0.855 |
 Female | 7 | 1330 [966–1641] |  | 1314 [1012–2427] |  | 1347 [700–1494] |  |
Age | |||||||
 < 70 | 15 | 1227 [384–1979] | 0.567 | 1307 [649–2069] | 0.750 | 1120 [252–1774] | 0.470 |
 > 70 | 11 | 1105 [528–2120] |  | 919 [531–2095] |  | 1519 [606–1987] |  |
Histology | |||||||
 Adenocarcinoma | 19 | 1112 [475–1519] | 0.488 | 1105 [733–1466] | 0.960 | 1120 [290–1519] | 0.147 |
 Others | 7 | 2078 [493–2475] |  | 1307 [487–2966] |  | 2216 [916–2442] |  |
Stage | |||||||
 I–II | 9 | 1105 [528–1520] | 0.566 | 800 [486–1224] | 0.520 | 1433 [762–1537] | 0.950 |
 III–IV | 17 | 1227 [384–2295] |  | 1307 [733–2456] |  | 1120 [281–2120] |  |
Grade | |||||||
 G2 | 4 | 1217 [916–1479]] | 0.946 | 1390 [1261–2230] | 0.628 | 734 [277–1219] | 0.490 |
 G3 | 16 | 922 [452–1658] |  | 922 [553–2003] |  | 1094 [286–1572] |  |
Smoking | |||||||
 Current | 12 | 860 [310–1437] | 0.215 | 1074 [722–2584] | 0.980 | 324 [223–972] | 0.006 |
 Formerb/Never | 14 | 1470 [733–2120] |  | 1126 [517–1590] |  | 1589 [1494–2237] |  |
COPD (GOLD) | |||||||
 0 | 15 | 1553 [826–2467] | 0.048 | 1307 [616–2711] | 0.456 | 2078 [1494–2412] | 0.004 |
 1–2 | 10 | 800 [324–1233] |  | 860 [508–1331] |  | 349 [281–1120] |  |